Matrixx Initiatives, Inc. has been engaged in the development and marketing of better ways to feel better through over-the-counter health care products that utilize innovative drug delivery systems for over 20 years. Acquired by HIG Capital in February 2011, Matrixx Initiatives manufactures and markets ZICAM® brand homeopathic and allopathic OTC products, including its clinically proven line of ZICAM® Cold Remedy Nasal Spray and Swab, ZICAM® Cold Remedy RAPIDMELTS® and Ultra RAPIDMELTS® and ZICAM® Cold Remedy Oral Mist™. Matrixx’s newest launch, ZICAM® Cold Remedy Ultra Crystals extends the oral line with on-the-go packets. Matrixx products also include ZICAM® Cold Remedy Relief for Kids, ZICAM® Allergy Relief Spray and Swab, ZICAM® Extreme Congestion Relief and ZICAM® Intense Sinus Relief. For more information regarding Matrixx products, please visit www.zicam.com.
Each of our products delivers an enhanced consumer experience or unique approach to respiratory ailments. Matrixx's ability to bring new products to market quickly, access and support distribution at retail, and engage the consumer with clear and compelling communication has enabled the company’s success and continued development of the Zicam brand with American consumers. Our innovative and convenient products help improve the lives of busy people who don't have time to be sidelined by illness.